Filters
Treatment with BRAF and MEK inhibitors for metastatic melanoma is associated with several ocular adverse effects (OAE), a study has shown.
In patients with soft tissue sarcoma (STS), preoperative radiation therapy (RT) performed at an academic cancer centre, as opposed to those done at a community centre, results in fewer wound complications following resection, according to a study.
Cervical cancer stands out as a major concern for older women who are frequently undertreated and are at higher risk of death, a study reports.
An observational single-institution cohort study provides evidence that levetiracetam use throughout the duration of standard chemotherapy is associated with longer median overall survival (OS) in patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma.
Poor environmental quality is associated with greater odds of an advanced stage prostate cancer at diagnosis, with a study finding the strongest associations for lower water, land, sociodemographic quality.
Enrolment in clinical trials does not seem to increase survival among patients with multiple myeloma, a recent study has found.
In the second-line treatment of patients advanced oesophageal cancer, the use of programmed cell death 1 (PD-1) inhibitors yields more favourable outcomes than chemotherapy across multiple patient subgroups, according to the results of a meta-analysis.
Cisplatin-based adjuvant chemotherapy confers substantial survival benefit in patients with muscle-invasive bladder cancer, reports a recent meta-analysis of randomized controlled trials (RCT).
Renal function considerably decreases over the long term for most bladder cancer patients who underwent radical cystectomy, a study has found.
Temozolomide administered to patients with glioblastoma at full actual body weight dosing during the concurrent phase is necessary to achieve a median overall survival (OS) that is similar to that seen in a previous trial, according to a recent study.
